Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Blankenstein, Thomas Prof. Dr. (11) Kieback, Elisa Dr. (1) Uckert, Wolfgang Prof. Dr. (3) Willimsky, Gerald Dr. (4) (-) Bunse, Mario Dr. (1) (-) Kammertöns, Thomas Dr. (2) (-) Kopp, Joachim Dr. (1) (-) Leisegang, Matthias Prof. Dr. rer. nat. (2) (-) Pezzutto, Antonio Prof. Dr. (1) 1997 (2) 1998 (3) 1999 (2) 2001 (1) 2003 (1) 2004 (4) 2006 (1) 2007 (2) 2009 (3) (-) 2010 (3) 2011 (4) 2012 (3) 2015 (4) (-) 2016 (2) 2017 (1) 2018 (2) 2019 (3) 2020 (3) 2021 (1) 2022 (3) 2023 (1) Cellular Neurosciences (2) Computational Regulatory Genomics (1) Experimental Ultrahigh-Field MR (4) Genome Engineering & Disease Models (2) Genomics (1) Immune Regulation and Cancer (3) Magnetic Resonance (4) Mechanism-based Cancer Therapies (1) Mobile DNA (1) (-) Molecular Immunology and Gene Therapy (5) Proteome Dynamics (1) RNA Biology and Posttranscriptional Regulation (1) Transgenics (2) 5 Results: Active Filter: Bunse, Mario Dr.Kammertöns, Thomas Dr.Kopp, Joachim Dr.Leisegang, Matthias Prof. Dr. rer. nat.Pezzutto, Antonio Prof. Dr.Molecular Immunology and Gene Therapy20102016 Sort: Result score Newest to oldest Oldest to newest March 01, 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein May 17, 2016 / Immunity Thymus-derived regulatory T cells are positively selected on natural self-antigen through cognate interactions of high functional avidity E. Kieback E. Hilgenberg U. Stervbo V. Lampropoulou P. Shen M. Bunse Y. Jaimes P. Boudinot A. Radbruch U. Klemm A.A. Kühl R. Liblau N. Hoevelmeyer S.M. Anderton W. Uckert S. Fillatreau April 15, 2010 / Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner March 01, 2010 / Hum Gene Ther Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma A. Buchner H. Pohla G. Willimsky B. Frankenberger R. Frank A. Baur-Melnyk M. Siebels C.G. Stief A. Hofstetter J. Kopp A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel March 01, 2010 / J Mol Med Leukemia-associated genetic aberrations in mesenchymal stem cells of children with acute lymphoblastic leukemia S. Shalapour C. Eckert K. Seeger M. Pfau J. Prada G. Henze T. Blankenstein T. Kammertoens
March 01, 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein
May 17, 2016 / Immunity Thymus-derived regulatory T cells are positively selected on natural self-antigen through cognate interactions of high functional avidity E. Kieback E. Hilgenberg U. Stervbo V. Lampropoulou P. Shen M. Bunse Y. Jaimes P. Boudinot A. Radbruch U. Klemm A.A. Kühl R. Liblau N. Hoevelmeyer S.M. Anderton W. Uckert S. Fillatreau
April 15, 2010 / Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner
March 01, 2010 / Hum Gene Ther Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma A. Buchner H. Pohla G. Willimsky B. Frankenberger R. Frank A. Baur-Melnyk M. Siebels C.G. Stief A. Hofstetter J. Kopp A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
March 01, 2010 / J Mol Med Leukemia-associated genetic aberrations in mesenchymal stem cells of children with acute lymphoblastic leukemia S. Shalapour C. Eckert K. Seeger M. Pfau J. Prada G. Henze T. Blankenstein T. Kammertoens